Actinium Pharmaceuticals
ATNM
ATNM
59 hedge funds and large institutions have $46.1M invested in Actinium Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
6.24% more ownership
Funds ownership: 11.37% → 17.62% (+6.2%)
17% less call options, than puts
Call options by funds: $3.46M | Put options by funds: $4.18M
Holders
59
Holding in Top 10
–
Calls
$3.46M
Puts
$4.18M
Top Buyers
| 1 | +$2.55M | |
| 2 | +$2.44M | |
| 3 | +$2.1M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$2.1M |
| 5 |
Two Sigma Advisers
New York
|
+$2.08M |
Top Sellers
| 1 | -$748K | |
| 2 | -$731K | |
| 3 | -$360K | |
| 4 |
William Blair & Company
Chicago,
Illinois
|
-$155K |
| 5 |
Franklin Resources
San Mateo,
California
|
-$153K |